nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—HRH1—GPCR downstream signaling—RHO—age related macular degeneration	0.00218	0.00218	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00215	0.00215	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—RHO—age related macular degeneration	0.00214	0.00214	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RDH8—age related macular degeneration	0.00211	0.00211	CbGpPWpGaD
Trimipramine—DRD2—G alpha (i) signalling events—C3—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—NMNAT1—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—RHO—age related macular degeneration	0.00202	0.00202	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RPE65—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—RHO—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—RHO—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—RHO—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—RHO—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—C3—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RPE65—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RPE65—age related macular degeneration	0.00193	0.00193	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RDH8—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RDH8—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00188	0.00188	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RDH8—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RPE65—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Trimipramine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RPE65—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Trimipramine—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Trimipramine—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—C3—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ABCA4—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Trimipramine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—C3—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RHO—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.000996	0.000996	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000995	0.000995	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000992	0.000992	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000979	0.000979	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.000977	0.000977	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000959	0.000959	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000956	0.000956	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000948	0.000948	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000926	0.000926	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000891	0.000891	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000887	0.000887	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000848	0.000848	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000818	0.000818	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000814	0.000814	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00079	0.00079	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.00078	0.00078	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000779	0.000779	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000775	0.000775	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.00077	0.00077	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000762	0.000762	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000758	0.000758	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000751	0.000751	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000726	0.000726	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000725	0.000725	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000718	0.000718	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000716	0.000716	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000708	0.000708	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000707	0.000707	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000705	0.000705	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000693	0.000693	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000692	0.000692	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000691	0.000691	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000687	0.000687	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000658	0.000658	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000658	0.000658	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000657	0.000657	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000645	0.000645	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000643	0.000643	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000642	0.000642	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000641	0.000641	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000632	0.000632	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000629	0.000629	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000625	0.000625	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000611	0.000611	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000602	0.000602	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000599	0.000599	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000597	0.000597	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000596	0.000596	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000589	0.000589	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000584	0.000584	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000579	0.000579	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000554	0.000554	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000543	0.000543	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000537	0.000537	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000511	0.000511	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000511	0.000511	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000502	0.000502	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CETP—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000492	0.000492	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000485	0.000485	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000472	0.000472	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000461	0.000461	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000457	0.000457	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000437	0.000437	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000435	0.000435	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000418	0.000418	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000409	0.000409	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.0004	0.0004	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000398	0.000398	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000389	0.000389	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000381	0.000381	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000371	0.000371	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000359	0.000359	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000356	0.000356	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000352	0.000352	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000352	0.000352	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000342	0.000342	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000339	0.000339	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000321	0.000321	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.00032	0.00032	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000315	0.000315	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000302	0.000302	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CD36—age related macular degeneration	0.000301	0.000301	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000296	0.000296	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000296	0.000296	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000291	0.000291	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000284	0.000284	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000221	0.000221	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.00021	0.00021	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000194	0.000194	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.00019	0.00019	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000186	0.000186	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000173	0.000173	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
